Trials / Conditions / Rotavirus Infection

Rotavirus Infection

14 registered clinical trials studyying Rotavirus Infection.

Status	Trial	Sponsor	Phase
Unknown	Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection NCT04626856	Chinese Academy of Medical Sciences	Phase 1
Completed	Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immu NCT05032391	Limited Liability Company Pharm Aid	Phase 3
Completed	This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix NCT03207750	GlaxoSmithKline	Phase 3
Completed	The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity NCT02992197	University of Vermont	Phase 4
Unknown	The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus NCT02662543	University of Tartu	—
Completed	A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine NCT01764256	PATH	Phase 1
Completed	Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules NCT01266850	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 4
Completed	Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Adminis NCT01511133	GlaxoSmithKline	—
Completed	Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected NCT00880698	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring NCT00895492	University of Chile	—
Completed	Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus NCT00683982	Centro Pediatrico Albina de Patino	N/A
Completed	Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children NCT00981877	Centro Pediatrico Albina de Patino	N/A
Completed	Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children NCT01328925	Romark Laboratories L.C.	Phase 2
Completed	Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children NCT00302640	Romark Laboratories L.C.	Phase 2 / Phase 3